Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Pregnancy Complications Clinical Trials

11 recruiting trials for Pregnancy Complications. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
11
Total Trials
11
Recruiting Now
1
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT06545994

A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS

The current study aims to investigate the dynamic serum kisspeptin levels throughout pregnancy and to explore its predictive value for GDM in PCOS.

Sponsor: Fudan UniversityEnrolling: 1801 location
RECRUITINGPhase 4NCT07361679

LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention

Preeclampsia is a major cause of maternal and perinatal morbidity and mortality worldwide. Low-dose aspirin started in the first trimester reduces the risk of preeclampsia in...

Sponsor: Alexandra Hospital, Athens, GreeceEnrolling: 1001 location
RECRUITINGNCT06110143

Oral Health and Adverse Pregnancy Complications

Pregnant women are susceptible to develop periodontitis, but these oral health changes related to pregnancy are often neglected. Periodontitis is accompanied by a low-grade...

Sponsor: University Hospital Bispebjerg and FrederiksbergEnrolling: 6003 locations
RECRUITINGPhase 3NCT05790252

Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)

The goal of this clinical trial is to compare buprenorphine patch for induction (starting) of buprenorphine in pregnant patients with opioid use disorder. The main questions it...

Sponsor: Washington University School of MedicineEnrolling: 401 location
RECRUITINGPhase 4NCT05114096

Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)

Antenatal corticosteroids (ACS) reduce the risks of neonatal death and morbidities in preterm infants, such as respiratory distress syndrome. The standard of care for pregnant...

Sponsor: McMaster UniversityEnrolling: 325420 locations
RECRUITINGNCT06367465

Feasibility and Acceptability of HCV Treatment in Pregnancy

Pregnant adults over the age of 18 who are seen in the Washington University obstetrics and gynecology, maternal fetal medicine or infectious diseases clinic or admitted to BJH...

Sponsor: Washington University School of MedicineEnrolling: 502 locations
RECRUITINGNCT05655936

Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial

This is a single site, single-blinded parallel randomized control trial that investigates a multi-level intervention to improve postpartum blood pressure in women with...

Sponsor: University of PittsburghEnrolling: 4541 location
RECRUITINGPhase 4NCT06281665

Treatment With Aspirin After Preeclampsia: TAP Trial

The objective of this research project is to conduct a single-site pilot trial to assess the feasibility and effect of low-dose aspirin to augment vascular recovery in the...

Sponsor: Malamo CountourisEnrolling: 601 location
RECRUITINGPhase 1 / Phase 2NCT06417411

LEARNER- Low dosE AspiRiN prEterm tRial (Angola)

This study is being conducted to evaluate the safety and effect of starting daily use of low dose (100 mg) aspirin in pregnant women with sickle cell disease, who are being...

Sponsor: Instituto Nacional de Investigacao em Saude, AngolaEnrolling: 4501 location
RECRUITINGNCT07414511

Hemophilia A Research Program

This study longitudinally observes the intergenerational (mother-child) continuum in hemophilia A from pregnancy through early childhood. Because the study follows mother-child...

Sponsor: University of WashingtonEnrolling: 5001 location
RECRUITINGNCT06941025

Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women...

The goal of this observational registry is to evaluate the safety and outcomes of pregnancy and lactation in women with Fabry disease who are exposed to pegunigalsidase alfa...

Sponsor: Chiesi Farmaceutici S.p.A.Enrolling: 105 locations